Aller au contenu principal
Profil bibliographique

Annette V. Jacobsen

Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.

32Publications signalées
1514Citations signalées
3Affiliations récentes

Les institutions déclarées

Les domaines associés

Cell death mechanisms and regulationinterferon and immune responsesPARP inhibition in cancer therapyNuclear Structure and FunctionHippo pathway signaling and YAP/TAZ

Les publications récentes

2026 article OpenAlex

A necroptotic-to-apoptotic signaling axis underlies inflammatory bowel disease

Jiyi Pang, Aysha Al‐Ani, Komal M. Patel, Yunzhuo Zhou et autres

Inflammatory bowel disease (IBD) is a chronic condition caused by altered cytokine signaling, maladaptive immunity, dysbiosis, and intestinal barrier dysfunction. Although current therapies aim to correct these imbalances to induce remission, most patients ultimately relapse, suggesting that key pathogenic mechanisms persist. Here, …

au, us, cn, kr, de, gb (code pays fourni par la source)

6 citations Science
Accès ouvert 2024 article OpenAlex

Inhibitors identify an auxiliary role for mTOR signalling in necroptosis execution downstream of MLKL activation

Sarah E. Garnish, Christopher R. Horne, Yanxiang Meng, Samuel N. Young et autres

Necroptosis is a lytic and pro-inflammatory form of programmed cell death executed by the terminal effector, the MLKL (mixed lineage kinase domain-like) pseudokinase. Downstream of death and Toll-like receptor stimulation, MLKL is trafficked to the plasma membrane via the Golgi-, actin- and …

au (code pays fourni par la source)

5 citations Biochemical Journal
Accès ouvert 2024 article OpenAlex

An immunohistochemical atlas of necroptotic pathway expression

Shene Chiou, Aysha Al‐Ani, Yi Pan, Komal M. Patel et autres

Necroptosis is a lytic form of regulated cell death reported to contribute to inflammatory diseases of the gut, skin and lung, as well as ischemic-reperfusion injuries of the kidney, heart and brain. However, precise identification of the cells and tissues that undergo …

au, us (code pays fourni par la source)

35 citations EMBO Molecular Medicine
Accès ouvert 2023 preprint OpenAlex

An immunohistochemical atlas of necroptotic pathway expression

Shene Chiou, Aysha Al‐Ani, Yi Pan, Komal M. Patel et autres

Abstract Necroptosis is a lytic form of regulated cell death reported to contribute to inflammatory diseases of the gut, skin and lung, as well as ischemic-reperfusion injuries of the kidney, heart and brain. However, precise identification of the cells and tissues that …

au, us (code pays fourni par la source)

2 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2023 article OpenAlex

A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation

Sarah E. Garnish, Katherine Martin, Maria Kauppi, Victoria E. Jackson et autres

Abstract Across the globe, 2-3% of humans carry the p.Ser132Pro single nucleotide polymorphism in MLKL, the terminal effector protein of the inflammatory form of programmed cell death, necroptosis. Here we show that this substitution confers a gain in necroptotic function in human …

au, gb, cn, de (code pays fourni par la source)

13 citations Nature Communications
Accès ouvert 2023 article OpenAlex

The VEGFR/PDGFR tyrosine kinase inhibitor, ABT-869, blocks necroptosis by targeting RIPK1 kinase

Catia L. Pierotti, Annette V. Jacobsen, Christoph Grohmann, Ruby K. Dempsey et autres

Necroptosis is a mode of programmed, lytic cell death that is executed by the mixed lineage kinase domain-like (MLKL) pseudokinase following activation by the upstream kinases, receptor-interacting serine/threonine protein kinase (RIPK)-1 and RIPK3. Dysregulated necroptosis has been implicated in the pathophysiology of …

au (code pays fourni par la source)

13 citations Biochemical Journal
Accès ouvert 2022 preprint OpenAlex

A common human MLKL polymorphism confers resistance to negative regulation by phosphorylation

Sarah E. Garnish, Katherine Martin, Maria Kauppi, Victoria E. Jackson et autres

ABSTRACT Across the globe, 2-3% of humans carry the p.Ser132Pro single nucleotide polymorphism in MLKL , the terminal effector protein of the inflammatory form of programmed cell death, necroptosis. We show that this substitution confers a gain in necroptotic function in human …

au, de (code pays fourni par la source)

0 citations bioRxiv (Cold Spring Harbor Laboratory)
Accès ouvert 2022 article OpenAlex

Development of NanoLuc-targeting protein degraders and a universal reporter system to benchmark tag-targeted degradation platforms

Christoph Grohmann, Charlene M. Magtoto, Joel R. Walker, Ngee Kiat Chua et autres

Abstract Modulation of protein abundance using t ag- T argeted P rotein D egrader (tTPD) systems targeting FKBP12 F36V (dTAGs) or HaloTag7 (HaloPROTACs) are powerful approaches for preclinical target validation. Interchanging tags and tag-targeting degraders is important to achieve efficient substrate degradation, …

au, us, gb (code pays fourni par la source)

44 citations Nature Communications
Accès ouvert 2022 article OpenAlex

The Lck inhibitor, AMG-47a, blocks necroptosis and implicates RIPK1 in signalling downstream of MLKL

Annette V. Jacobsen, Catia L. Pierotti, Kym N. Lowes, Amanda E. Au et autres

Necroptosis is a form of caspase-independent programmed cell death that arises from disruption of cell membranes by the mixed lineage kinase domain-like (MLKL) pseudokinase after its activation by the upstream kinases, receptor interacting protein kinase (RIPK)-1 and RIPK3, within a complex known …

au (code pays fourni par la source)

22 citations Cell Death and Disease

BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.